Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
acute kidney injury
acute myocardial infarction AMI aneurysm aortic disease aortic regurgitation atrial fibrillation atrial myopathy biomarker biomarkers carbohydrate antigen-125 cardiac biomarkers cardiac intensive care units cardiac magnetic resonance imaging cardiometabolic disease cardiometabolic risks cardiovascular death cardiovascular diseases cardiovascular events cardiovascular risk cardiovascular surgery catestatin cell adhesion molecule ceramides ceruloplasmin chronic heart failure chronic kidney disease circulating cells circulating miRNAs CKD cohort studies coronary artery disease CVD diet quality echocardiography ejection fraction epicardial adipose tissue epicardial fat epicardial fat volume FABP3 fatty acid-binding protein 3 Framingham risk score GDF-15 GDF8 growth differentiation factor 15 (GDF-15) H-FABP healthy eating index heart failure heart failure decompensation heart-type fatty acid-binding protein heart-type fatty acid-binding protein (H-FABP) herat failure HF HFpEF HFrEF hypertension inflammatory marker KLF4 left ventricular adverse remodelling left ventricular ejection fraction left ventricular systolic function liver-type fatty-acid-binding protein long-term outcomes longitudinal strain magnetic resonance imaging magnetic resonance spectroscopy metabolic syndrome microRNA miRNA mitochondrial DNA (mtDNA) mitochondrial dysfunction muscle wasting myocardial infarction myocardial triglyceride content myostatin n/a NAFLD NAFLD fibrosis score NT-proBNP NYHA functional class obesity older women operative risk oxidative stress PBMCS Pentraxin-3 platelets PPCI pregnancy-associated plasma protein-A primary prevention reactive oxygen species (ROS) renal dysfunction repeated measurements risk prediction risk stratification saliva salivary biomarkers sarcopenia secondary prevention SOCE soluble suppression of tumorigenicity 2 (sST2) soluble urokinase-type plasminogen activator receptor (suPAR) sST2 STEMI STIM1 sudden cardiac death suPAR synthetic phenotype T1 mapping TGF-β pathway thyroid-stimulating hormone troponin vena contracta area ventricular arrhythmia ventricular tachycardia very low-density lipoprotein |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Radiation Response Biomarkers for Individualised Cancer Treatments
| Radiation Response Biomarkers for Individualised Cancer Treatments |
| Autore | Badie Christophe |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (231 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
abscopal effect
biodosimetry biological dosimetry biomarker biomarkers cancer carbon-ion radiotherapy cGAS chromosomal instability chromosome aberrations circulating biomarkers circulating tumour cells clonogenic assays dicentric assay exosomes extracellular vesicles gamma H2AX foci assay GC/MS genotoxicity tests head and neck cancer head-and-neck tumors health surveillance analyses human blood immune infiltrate immune system immunotherapy IMRT individual radiosensitivity inflammation inversions ionizing radiation late effects liquid biopsy lung cancer machine learning metabolomics methods micronuclei micronucleus assay microRNA microRNAs n/a normal tissue normal tissue toxicity PBMCS personalized medicine plating pneumonitis predictive tests prostate cancer protein proteomics radiation radiation-induced lung fibrosis radiation-induced lung injury radiosensitivity radiotherapy radiotherapy monitoring relative biological effectiveness RILF RILI serum squamous cell carcinoma STING stroma telomeres tumour microenvironment uterine cervical cancer |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557345403321 |
Badie Christophe
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||